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ABSTRACT
Pregnancies with a male fetus are associated with higher risks of pregnancy compli-
cations through maladaptation of the maternal immune system. The pathophysiology 
of this phenomenon is unknown. A possible pathway could be a fetal sex dependent 
maternal immune response, since males have a Y chromosome encoding specific 
allogenic proteins, possibly contributing to a different response and higher compli-
cation risks.
To analyze whether fetal sex affects mRNA expression of maternal immune genes 
in early pregnancy, real-time PCR quantification was performed in decidual tissue 
from primigravid pregnancies (n=20) between 10 and 12 weeks with uncomplicated 
term outcomes.
Early pregnancy decidual mRNA expression of the regulatory T-cell marker, 
FOXP3 was 6-fold lower (p<0.001) in pregnancies with a male fetus compared to 
pregnancies with a female fetus. Additionally, mRNA expression of IFNγ, was 6-fold 
(p<0.01) lower in pregnancies with a male fetus.
The present data imply maternal immunologic differences between pregnancies 
with male and female fetuses which could be involved in different pregnancy pathop-
hysiologic outcomes. Moreover, this study indicates that researchers in reproductive 
immunology should always consider fetal sex bias.
INTRODUCTION
Pregnancies with a male fetus have a higher incidence of preterm birth, gestational 
diabetes mellitus, and preeclampsia1–4. The pathophysiology of this phenomenon is 
unknown. Since these complications of pregnancy are associated with maladaptation 
of the maternal immune system5, a possible pathway could lie in a fetal sex dependent 
maternal immune response. An explanation might be found in the Y chromosome in 
males which encodes specific allogenic proteins, possibly contributing to a different 
maternal immune response when a male fetus is carried.
A number of studies have shown that the maternal immune system develops a 
fetus-specific immune response6–8. Moreover, studies demonstrated fetal sex-specific 
cytokine levels in maternal peripheral blood during, and after pregnancy9–11. Additio-
nally, fetal sex was found to affect cytokine expression in placental tissue in asthmatic 
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pregnant women12,13. Until now, differences in the maternal immune response between 
pregnancies with male or female fetuses were only shown in the peripheral blood and 
post-partum placental tissue. Whether a fetal sex-specific immune response is elicited 
at the fetal maternal interface already in early pregnancy, is unknown.
T-regulatory cells (Tregs) are of particular interest in complicated as well as uncom-
plicated pregnancies because of their immunosuppressive properties14. Tregs skew 
the pro-inflammatory T-helper 1 response to the more tolerating T-helper 2 response14. 
Adequate function and optimal numbers of Tregs are essential for normal implanta-
tion and pregnancy outcome, and a lack of adequate Treg numbers is associated 
with adverse pregnancy outcomes such as preeclampsia, implantation failure, and 
infertility14–16. The transcription factor forkhead box protein P3 (FOXP3) has been 
identified as the immunosuppressive protein and marker for Tregs17. Whether modu-
lation of the Treg population is dependent on fetal sex, and whether Tregs play a 
role in the etiology of higher rates of pregnancy complications in pregnancies with 
a male fetus is unknown.
Besides Tregs, other immune cells such as macrophages contribute to tolerance 
in early pregnancy by shifting towards a more tolerating M2 phenotype, and by 
releasing cytokines which contribute to implantation and tissue remodeling18,19. 
Fetal sex-specific differences in activation and cytokine profiles of macrophages in 
placental tissue were found in a mouse study20. Early-pregnancy alterations in mRNA 
expression of macrophage associated genes in pregnancies with complicated out-
comes were demonstrated21. However, to our knowledge neither human studies nor 
early-pregnancy-studies concerning sex-specific macrophages have been performed.
T-lymphocytes and macrophages secrete cytokines that contribute to either a pro-in-
flammatory or an anti-inflammatory environment. Both pro- and anti-inflammatory 
cytokines play a role in implantation, placentation and pregnancy success22. Whereas 
IL1b and interferon-γ (IFNɣ) secretion at the fetal maternal interface seems beneficial 
for successful implantation23, increased levels of IL6 at term are associated with 
preterm delivery and neonatal morbidity24,25. Presumably, the timing and amount of 
secretion determines whether a cytokine at a certain stage of pregnancy is beneficial 
for pregnancy maintenance.
The aim of this study is to analyze fetal sex-dependent differences in mRNA expres-
sion of maternal FOXP3, macrophage, and other immune associated gene parameters 
at the fetal maternal interface in early pregnancies that developed uneventful. Hence, 
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unique first trimester decidual tissue from ongoing human pregnancies with known 
uncomplicated term outcomes was studied.
METHODS
First trimester decidual tissue was obtained from surplus tissue at vaginally sam-
pled chorionic villus sampling (CVS), between 10 and 12 weeks of gestation for 
maternal age (over 36 years of age at 18 weeks of gestation) screening related 
risk for aneuploidy following the protocol from Huisman et al.26. Karyotype analysis 
was performed for all samples and the karyogram appeared normal for all fetuses. 
Immediately after sampling, decidual tissue was microscopically separated from villi 
to minimize trophoblast contamination. Subsequently, samples were stored until further 
analysis following the protocol from Huisman et al.26.
Table 1. Characteristics of patient groups
Pregnancies with a female fetus
(n=8)
Pregnancies with a male fetus
(n=8)
At CVS
Maternal age (years) 37.4 ± 0.81 39.5 ± 0.46




Gestational age (weeks) 40.5 ± 0.55 41.0 ± 0.60
Birth weight (grams) 3588 ± 120.42 3444 ± 149.41
(mean ± SEM), chorionic villus sampling (CVS), characteristics were compared between groups using 
Mann-Whitney U test with Bonferroni multiple comparison correction
Patients were informed that otherwise discarded material could be used for research 
according to the ‘Guideline Good Use’ by the FMWV-committee (Federation of Medi-
cal Scientific Associations). Follow-up of pregnancies was available by questionnaires 
postpartum. Patients on medication, with a history of smoking, diabetes mellitus, or 
other co morbidities were excluded from the study.
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Decidual tissue from 20 uncomplicated primiparous pregnancies was randomly 
selected (10 boys and 10 girls) (see Table 1). All women participating in this study 
were primigravid, did not undergo assisted reproductive techniques, and did not 
take any medication apart from folic acid. Based on Nanodrop quantity analy-
sis, 4 samples were excluded (2 boys, 2 girls). RNA was isolated and purified; 
QIAzol lysis reagent (Qiagen, USA) was added, and samples were homogenized 
using a Tissuelyser (Qiagen); 2 minutes, 50 Hertz. Thereafter RNA was isolated 
using RNAeasy plus mini-kit (Qiagen). cDNA was reverse transcribed using Supers-
cript-II Reverse Transcriptase kit (Invitrogen, USA). Three house-keeper genes (HPRT, 
GAPDH, and ACTB) were analyzed. HPRT was the most consistent in all samples 
and was therefore used for analysis. mRNA expression of TBX21 (T-helper 1 (Th1) 
response), GATA3 (T-helper 2 (Th2) response), RORC (T-helper 17 (Th17 response), 
FOXP3 (Treg marker), Interleukin 6 (IL6), IL1b, interferon-γ (IFNɣ), CD68 (macrop-
hage), IRF5 (M1 macrophages), and MRC1 (M2 macrophages) was analyzed using 
Taqman On-Demand-Gene-Expression Assays (Thermofisher, USA).
PCR reactions were performed in triplicates in a volume of 10μL consisting of 14ng 
RNA, Mastermix (Thermofisher, USA) and RNA free water. Runs were performed on 
a ViiA7 Real-time PCR System (Thermofisher, USA), mRNA data were normalized to 
HPRT mRNA expression using 2-ΔCt. Undetectable cycle threshold (Ct) values (>40) 
were analyzed as maximum Ct value (40). Outliers were excluded using Grubb’s 
test. For analysis, GraphPad Prism version 5.04 for Microsoft Windows (Graph-
Pad Software, USA) was used. Differences between the groups were evaluated 
using Mann-Whitney U test with Bonferroni multiple comparison correction. p values 
<0.05 were considered statistically significant.
RESULTS AND DISCUSSION
In pregnancies with a male fetus there was a 6-fold significantly lower mRNA 
expression of FOXP3 (p<0.01) compared to pregnancies with a female fetus (see 
Figure 1). In both human and murine studies it has been shown that Tregs play a role 
in healthy implantation and placental development in early pregnancy27,28. The lower 
expression of FOXP3 in first-trimester decidual tissue from pregnancies with a male 
fetus could imply an inferior maternal immune tolerance in early pregnancies with a 
male fetus possibly contributing to a higher risk of pregnancy complications14. 
An explanation for the fetal sex-specific difference in mRNA expression of 
FOXP3 could be the presence of the Y chromosome in males, which encodes minor 
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histocompatibility antigens (HY)29. HY antigens are expressed in first trimester placen-
tal tissue and can be recognized by maternal T-lymphocytes eliciting an HY-specific 
immune response11,30,31. Only a limited number of studies are performed on the ability 
of fetal HY antigens to induce or suppress maternal FOXP3 mRNA expression and 
Treg cells32,33. Kahn et al. showed that HY induces an HY-specific Treg population that 
contributes to tolerance in mice, however, no comparison with HY absent pregnancies 
(solely female fetuses) was made. Therefore, no conclusions of the effects of fetal sex 
on FOXP3 induction can be made33. Our results show that mRNA expression of the 
Treg marker FOXP3 is affected by fetal sex, however more research is necessary to 
clarify the role of HY in the difference of mRNA expression between pregnancies 
with a male and a female fetus.
Figure 1. mRNA expression of T-lymphocyte markers and cytokines in first trimester human decidual tissue. 
Data are mean ± SEM mRNA target gene expression normalized to house-keeper gene HPRT, in decidu-
al tissue from pregnancies with a female fetus (open bars, n=8), and pregnancies with a male fetus (black 
bars, n=8). Comparison between groups was evaluated using Mann-Whitney U test with Bonferroni 
multiple comparison correction; *p<0.05, **p<0.01.
In addition, significantly higher mRNA expression of IFNγ (p<0.05) was found in 
pregnancies with a female fetus (see Figure 1). Many studies have associated incre-
ased IFNγ in different tissues with pregnancy complications such as pre-eclampsia34. 
Therefore, this finding could appear contradictory to the hypothesis in which male 
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fetuses have a less favorable maternal immune environment in pregnancy. However, 
the pro-inflammatory cytokine, which is encoded by the IFNγ gene, has also been 
shown to be favorable for pregnancy22,35,36. Especially in early pregnancy, IFNγ 
has been demonstrated to be important22,35,36. IFNγ plays a role in implantation, 
placentation, and continuation of pregnancy22,35,36. Higher decidual IFNγ at term 
was associated with pre-eclampsia, however women delivering preterm had lower 
IFNγ at mid gestation compared to women delivering at term34,37,38. These data imply 
that IFNγ synthesis is beneficial in early pregnancy to mid gestation and is unfa-
vorable for pregnancy success in the third trimester36. Furthermore, IFNγ has been 
shown to be indispensable for the conversion of non-Treg cells into Treg cells37,38. 
Since we found higher mRNA expression of both IFNγ and FOXP3 it could be pos-
tulated that during early pregnancy the higher expression of IFNγ is necessary for 
a robust implantation and placentation, and that the possible compensatory higher 
expression of FOXP3 mRNA is necessary to dampen the effect of pro-inflammatory 
cytokines for successful pregnancy outcome. Herewith, the differences found in 
this study support the hypothesis that a difference in maternal immune response 
depending on fetal sex plays a role in 
the different incidences of pregnancy 
complications between pregnancies with 
a male or a female fetus. Our findings 
are in line with previous studies which 
showed altered fetal sex-specific cyto-
kine levels in peripheral maternal blood 
during pregnancy and in placental tissue 
after delivery9,10,12,13.
In this study, no fetal sex-specific diffe-
rences in mRNA expression of macrop-
hage markers were found (see Figure 
2). Macrophage mRNA expression is 
possibly not influenced by fetal sex at 
this early stage of pregnancy, as in 
an obesity mouse model where a fetal 
sex-specific difference in macrophage 
activation was seen in late pregnancy 
but not in early pregnancy placental 
tissue20. Or, alternatively, our sample 
size is too small to detect these changes.
Figure 2. mRNA expression of macrophage mar-
kers in first trimester human decidual tissue. Data 
are mean ± SEM mRNA target gene expression 
normalized to house-keeper gene HPRT, in deci-
dual tissue from pregnancies with a female fetus 
(open bars, n=8), and pregnancies with a male 
fetus (black bars, n=8). Comparison between 
groups was evaluated using Mann-Whitney U test 
with Bonferroni multiple comparison correction.
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This study uses first trimester decidual tissue from pregnancies with uncomplicated 
outcomes, which is unique and almost unobtainable. With the current knowledge 
on risks of pregnancy complications caused by CVS, and the availability of alter-
native techniques39, nowadays, CVS is not routinely performed anymore. The first 
trimester decidual tissue used in this study, is therefore highly appreciated and a 
unique possibility that enabled analysis of immune parameters in early pregnancies 
with known outcome. To limit the risks of pregnancy complications, the tissue volume 
taken with CVS was reduced to the smallest amount. The remaining tissue volume 
after diagnostic tests was only sufficient for PCR analysis of the genes shown and no 
further experiments could be performed. Therefore, actual protein synthesis and cell 
quantification were not investigated in this study. However, the differences in mRNA 
expression shown in this study do imply differences in the maternal immune response 
between pregnancies with a male and a female fetus. Further research is necessary 
to elucidate whether the different mRNA expression found, does coincide with protein 
expression and the immune environment in early pregnancy.
In general, despite growing evidence showing the effects of fetal sex on the mater-
nal immune response, still most studies performed in reproductive research do not 
consider a fetal sex bias blurring their results. As this study shows that the maternal 
immune response differs depending on fetal sex, we propose that fetal sex differences 
between groups should always be considered. 
CONCLUSIONS
In summary, this study shows fetal sex-specific differences in mRNA expression of 
maternal immune factors in first trimester decidual tissue. Lower mRNA expression 
of FOXP3 and the pro-inflammatory cytokine encoding gene IFNγ were found in 
uncomplicated pregnancies with a male fetus compared to pregnancies with a female 
fetus. In the first trimester decidual tissue studied, no differences for mRNA expression 
of macrophage markers were found. 
These findings imply a fetal sex dependent maternal immune response, which could 
be involved in the pathophysiology responsible for the higher incidence of adverse 
pregnancy outcomes in pregnancies with a male fetus. Moreover, this study supports 
that reproductive immunology research should always consider fetal sex bias.
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